U.S. Cases of congenital syphilis, a heartbreaking and preventable condition, continue to rise, though recent data suggest a potential turning point in the broader sexually transmitted infection (STI) landscape. New provisional data from the Centers for Disease Control and Prevention (CDC) show nearly 4,000 cases of newborn syphilis were reported in 2024, marking the 12th consecutive year of increase. However, the rate of increase has slowed, climbing nearly 2% over 2023 – a notable shift from the double-digit increases seen in recent years. This complex public health challenge demands continued vigilance and expanded prevention efforts, particularly as overall STI rates remain substantial.
The surge in congenital syphilis – when a mother passes the infection to her baby during pregnancy – represents a significant setback in public health. Since 2015, when 495 cases were reported, the number has skyrocketed, increasing by nearly 700%. The consequences for affected infants can be devastating, including stillbirth, premature birth, and severe health problems. The CDC emphasizes that congenital syphilis is entirely preventable with timely screening and treatment during pregnancy.
A Broader STI Picture: Declines Amidst High Numbers
While congenital syphilis remains a critical concern, the latest CDC data reveal encouraging trends in other areas of STI prevalence. In 2024, overall reported STIs declined by 9% compared to 2023, marking the third consecutive year of decline. This decrease is driven by reductions in several key infections. Primary and secondary syphilis, the most infectious stages of the disease, fell by nearly 22%, also for the second year in a row. Gonorrhea cases decreased by almost 10%, and chlamydia cases dropped by 8%, both representing a third and second consecutive year of decline, respectively.
These positive shifts are attributed to increased public health initiatives, including heightened awareness of the STI epidemic and greater access to prevention tools. The Food and Drug Administration (FDA) recently authorized marketing of a self-test for syphilis, expanding access to early detection. The use of doxycycline post-exposure prophylaxis (doxy PEP) – taking antibiotics after potential exposure to syphilis – is gaining traction as a preventative measure, as outlined by the CDC’s guidelines.
Disparities and Regional Variations
Despite the national progress, the CDC cautions that the STI landscape is not uniform across the country. Trends vary significantly by region and population group, and some communities may still be experiencing increases not reflected in the national data. Addressing these disparities requires targeted interventions and a deeper understanding of the factors driving transmission in specific areas. Public health officials emphasize the need for continued investment in local STI programs and culturally sensitive outreach efforts.
Bradley Stoner, M.D., Ph.D., Director of CDC’s Division of STD Prevention, underscored the importance of sustained effort. “While the STI epidemic may be turning a corner, we must accelerate progress and stop its most tragic consequences,” he stated. “About 1 in 5 people in the United States have an STI, affecting millions of Americans and thousands of babies each year. We need to continue our prevention efforts wholeheartedly at federal, state, and local levels.”
The Ongoing Burden and Future Steps
Even with the recent declines, the overall STI burden in the United States remains substantial. More than 2.2 million cases were reported in 2024, a 13% increase since 2015. This highlights the ongoing need for comprehensive STI prevention strategies, including increased access to testing, treatment, and vaccination (where available). The CDC continues to fund and support state and local health departments in their efforts to combat the STI epidemic, providing resources for surveillance, prevention programs, and workforce development.
The CDC’s annual STI statistics report provides detailed data on STI trends and prevalence across the country. Individuals can identify information about STI testing and prevention on the CDC’s website, including resources for finding local testing sites and learning about safe sex practices.
The next update on national STI trends is expected in September 2026, when the CDC releases provisional data for 2025. Continued monitoring and evaluation of prevention efforts will be crucial to sustaining the recent progress and ultimately reducing the burden of STIs in the United States.
Have something to say about this story? Share your thoughts in the comments below.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
